According to our (Global Info Research) latest study, the global GMP-Grade iPSC Master Cell Bank market size was valued at US$ 293 million in 2025 and is forecast to a readjusted size of US$ 795 million by 2032 with a CAGR of 15.2% during review period.
GMP-grade iPSC master cell banks (MCBs) are clinical-grade induced pluripotent stem cell repositories established under GMP or equivalent quality systems. They are derived from donor-derived somatic cells through ethical sourcing (informed consent and donor screening), followed by reprogramming, clone selection, expansion, cryopreservation, and full release testing. These MCBs serve as stable starting materials for the generation of working cell banks (WCBs), gene-edited iPSC lines, directed differentiation products, and downstream cell therapy manufacturing. Their value lies in compliant donor traceability, non-integrating reprogramming methods, genetic stability, sterility and adventitious agent testing, full batch traceability, regulatory documentation readiness, and long-term cryogenic storage management. The estimated gross margin is approximately 58%.
Demand is primarily driven by allogeneic iPSC-based cell therapies, regenerative medicine products, disease modeling platforms, and drug discovery systems. As clinical programs in immune cells, cardiomyocytes, neurons, retinal cells, and other iPSC-derived lineages advance toward late-stage development, developers increasingly prefer GMP-compliant starting materials from the earliest stages. This reduces the risk of re-establishing cell lines, repeating process development, or facing regulatory setbacks later in the development pipeline.
The supply landscape is evolving from standalone cell banking services toward integrated platforms offering clinical-grade seed clones, master cell banks, working cell banks, gene editing services, and regulatory submission documentation packages. Core competitive factors include donor compliance and traceability, non-integrating reprogramming methods, low-passage expansion strategies, genomic and karyotypic stability, viral and adventitious agent testing, closed-system GMP manufacturing workflows, DMF or IND/CTA-ready documentation packages, and demonstrated comparability between research-grade and GMP-grade cell lines.
Regionally, North America, Europe, and Japan lead in regulatory experience, clinical-grade banking infrastructure, and CDMO capabilities. China and South Korea are rapidly scaling domestic GMP iPSC platforms. Key risks include donor authorization complexity, intellectual property constraints, divergent regulatory interpretations across jurisdictions, long release-testing cycles, and high batch production costs. Key opportunities lie in off-the-shelf HLA-matched cell banks, hypoimmunogenic gene-edited iPSC libraries, automated manufacturing systems, and standardized regulatory documentation ecosystems.
Report Scope
This report is a detailed and comprehensive analysis for global GMP-Grade iPSC Master Cell Bank market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global GMP-Grade iPSC Master Cell Bank market size and forecasts, in consumption value ($ Million), 2021-2032
Global GMP-Grade iPSC Master Cell Bank market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global GMP-Grade iPSC Master Cell Bank market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global GMP-Grade iPSC Master Cell Bank market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GMP-Grade iPSC Master Cell Bank
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GMP-Grade iPSC Master Cell Bank market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FUJIFILM Cellular Dynamics, REPROCELL, Cellistic, I Peace, LineaBio, Catalent, Applied StemCell, CiRA Foundation, Ubrigene, Minaris Advanced Therapies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
GMP-Grade iPSC Master Cell Bank market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Off-the-Shelf GMP iPSC MCB
Custom GMP iPSC MCB
Customer-Owned Line GMP Banking
Technology-Transfer GMP MCB Manufacturing
Market segment by Starting Cell Source
CD34+ Cord Blood-Derived iPSC MCB
Peripheral Blood-Derived iPSC MCB
Fibroblast-Derived iPSC MCB
T Cell-Derived iPSC MCB
Other Somatic Cell-Derived iPSC MCB
Market segment by Quality Documentation Level
Basic GMP-Released iPSC MCB
Extended Characterized iPSC MCB
Viral Safety-Tested iPSC MCB
Filing-Ready iPSC MCB
DMF-Supported iPSC MCB
Market segment by Engineering Status
Unedited iPSC MCB
Reporter or Selection-Marker Edited iPSC MCB
Disease-Model or Corrected iPSC MCB
Immune-Evasion Edited iPSC MCB
Other Engineered iPSC MCB
Market segment by Application
Immune Cell Therapy Development
Regenerative Cell Therapy Development
Gene-Edited Platform Cell Development
Disease Modeling and Drug Screening
Toxicology and Safety Evaluation
Other Clinical Research
Market segment by players, this report covers
FUJIFILM Cellular Dynamics
REPROCELL
Cellistic
I Peace
LineaBio
Catalent
Applied StemCell
CiRA Foundation
Ubrigene
Minaris Advanced Therapies
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe GMP-Grade iPSC Master Cell Bank product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of GMP-Grade iPSC Master Cell Bank, with revenue, gross margin, and global market share of GMP-Grade iPSC Master Cell Bank from 2021 to 2026.
Chapter 3, the GMP-Grade iPSC Master Cell Bank competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and GMP-Grade iPSC Master Cell Bank market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of GMP-Grade iPSC Master Cell Bank.
Chapter 13, to describe GMP-Grade iPSC Master Cell Bank research findings and conclusion.
Summary:
Get latest Market Research Reports on GMP-Grade iPSC Master Cell Bank. Industry analysis & Market Report on GMP-Grade iPSC Master Cell Bank is a syndicated market report, published as Global GMP-Grade iPSC Master Cell Bank Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of GMP-Grade iPSC Master Cell Bank market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.